Tandem Diabetes Care | TNDM - Operating Expenses


Tandem Diabetes Care reported $272.12M in Operating Expenses for its fiscal quarter ending in September of 2025.





Operating Expenses Change Date
Abbott USD 9.21B 17M Dec/2025
Align Technology USD 811.05M 38.37M Sep/2025
AtriCure USD 134.06M 8.27M Sep/2025
Baxter International USD 2.63B 95.8M Sep/2025
Becton, Dickinson and Co. USD 5.07B 535M Sep/2025
Boston Scientific USD 4.03B 94M Sep/2025
Cooper Companies USD 924.8M 40.2M Sep/2025
Dexcom USD 966.8M 22.3M Sep/2025
Edwards Lifesciences USD 1.13B 26.7M Sep/2025
Eli Lilly USD 9.21B 677.8M Sep/2025
Globus Medical USD 886.57M 730.06M Sep/2025
ICU Medical USD 510.13M 11.93M Sep/2025
Insulet USD 588.6M 60.6M Sep/2025
Integra LifeSciences USD 1.04B 620.66M Sep/2025
Intuitive Surgical USD 2B 263.6M Dec/2025
J&J USD 18.97B 2.38B Dec/2025
Masimo USD 147M 159.4M Sep/2025
Medtronic USD 7.26B 283M Sep/2025
Merit Medical Systems USD 341.54M 6.11M Sep/2025
Roche Holding CHF 21.01B 10.84B Dec/2025
Stryker USD 5.2B 505M Dec/2025
Tandem Diabetes Care USD 272.12M 421K Sep/2025
Teleflex USD 3.82B 3.22B Sep/2025
Zimmer Biomet Holdings USD 1.66B 17.8M Sep/2025